U.S. FDA approves Roche's small cell lung cancer treatment

Swiss drugmaker Roche Holding AG's U.S. unit Genentech said on Monday its immunotherapy Tecentriq won approval for a tough-to-treat type of lung cancer, the latest win for the drug whose sales trail medicines from Merck & Co and Bristol-Myers Squibb.

from Reuters: Company News https://ift.tt/2TgD67h
via IFTTT